期刊
NATURE PROTOCOLS
卷 5, 期 6, 页码 1033-1041出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nprot.2010.73
关键词
-
资金
- ANRS
- Korea Science and Engineering Foundation
- Institut Pasteur Korea
To advance T cell-based HIV vaccine development, it is necessary to evaluate the immune correlates of a protective CD8(+) T-cell response. We have developed an assay that assesses the capacity ex vivo of HIV-specific CD8(+) T cells to suppress HIV-1 infection of autologous CD4(+) T cells. this assay directly reflects the ultimate effector function of CD8(+) T cells, the elimination of infected cells, and accurately differentiates the effective CD8(+) T-cell response in spontaneous HIV controllers from ineffective responses in other patients. In this article, we describe all the steps from cell purification to assessment of viral replication by HIV-p24 ELISA and analysis, along with conditions for cell culturing, and how to choose the viral infectious dose that gives the most reliable results. We also depict the conditions of a rapid assay on the basis of flow cytometry analysis of intracellular HIV-Gag products. these procedures take 14-17 d when the p24 ELISA assay is used, or 6 d with the intracellular Gag assay.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据